Interleukin 2 deficiency induces bone destruction associated with dysregulation of the Rank/Rank Ligand/Osteoprotegerin system.

被引：0
|
作者：
Ashcroft, AJ
Lippitt, JM
Perry, MJ
Rollinson, SJ
Croucher, PI
Carding, SR
Morgan, GJ
机构：
[1] Univ Leeds, Acad Unit Haematol & Oncol, Leeds LS2 9JT, W Yorkshire, England
[2] Univ Leeds, Sch Biochem & Mol Biol, Leeds LS2 9JT, W Yorkshire, England
[3] Univ Sheffield, Dept Genom Med, Sheffield S10 2TN, S Yorkshire, England
[4] Univ Bristol, Sch Vet, Bristol BS8 1TH, Avon, England
[5] Univ Oxford, Nuffield Dept Orthopaed Surg, Oxford, England
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3403
引用
收藏
页码：819A / 819A
页数：1
相关论文
共 50 条
  • [21] Role of RANKL-RANK/Osteoprotegerin Pathway in Cardiovascular and Bone Disease Associated with HIV Infection
    Kelesidis, Theodoros
    Currier, Judith S.
    Yang, Otto O.
    Brown, Todd T.
    AIDS REVIEWS, 2014, 16 (03) : 123 - 133
  • [22] The role of RANK ligand/OPG system in bone erosions in rheumatoid arthritis
    Piet Geusens
    Arthritis Research & Therapy, 14 (Suppl 2):
  • [23] The role of RANK ligand/OPG system in bone erosions in rheumatoid arthritis
    Geusens, Piet
    ARTHRITIS RESEARCH & THERAPY, 2012, 14
  • [24] Lactation induces increases in the RANK/RANKL/OPG system in maxillary bone
    Macari, Soraia
    Sharma, Lavanya A.
    Wyatt, Amanda
    da Silva, Janine Maira
    Dias, George J.
    Silva, Tarcilia A.
    Szawka, Raphael E.
    Grattan, David R.
    BONE, 2018, 110 : 160 - 169
  • [25] Osteoclast mediated bone destruction in collagen-induced arthritis is revealed by targeting the RANKL-RANK interaction with osteoprotegerin
    Romas, E
    Sims, NA
    Quinn, JMW
    Dunstan, CR
    Martin, TJ
    Gillespie, MT
    BONE, 2003, 32 (05) : S159 - S159
  • [26] Mixed periodontal Th1-Th2 cytokine profile in Actinobacillus actinomycetemcomitans-specific osteoprotegerin ligand (or RANK-L)-mediated alveolar bone destruction in vivo
    Teng, YTA
    INFECTION AND IMMUNITY, 2002, 70 (09) : 5269 - 5273
  • [27] Osteoprotegerin (OPG)/RANK-L system in juvenile idiopathic arthritis: Is there a potential modulating role for OPG/RANK-L in bone injury?
    Masi, L
    Simonini, G
    Piscitelli, E
    Del Monte, F
    Giani, T
    Cimaz, R
    Vierucci, S
    Brandi, ML
    Falcini, F
    JOURNAL OF RHEUMATOLOGY, 2004, 31 (05) : 986 - 991
  • [28] Association of polymorphisms in the receptor activator of nuclear factor- KappaB (RANK), RANK ligand, osteoprotegerin, and interleukin 17 genes with disease severity in Japanese patients with rheumatoid arthritis.
    Furuya, T
    Ichikawa, A
    Kogame, A
    Nanke, Y
    Higami, K
    Hakoda, M
    Kamatani, N
    Kotake, S
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S354 - S354
  • [29] Cross-talk between the interleukin-6 and prostaglandin E2 signaling systems results in enhancement of osteoclastogenesis through effects on the osteoprotegerin/receptor activator of nuclear factor-κB (RANK) ligand/RANK system
    Liu, XH
    Kirschenbaum, A
    Yao, S
    Levine, AC
    ENDOCRINOLOGY, 2005, 146 (04) : 1991 - 1998
  • [30] IGF-I increases markers of osteoblastic activity and reduces bone resorption via osteoprotegerin and RANK-ligand
    Lucia Guerra-Menéndez
    Maria C Sádaba
    Juan E Puche
    Jose L Lavandera
    Luis F de Castro
    Arancha R de Gortázar
    Inma Castilla-Cortázar
    Journal of Translational Medicine, 11
12345